Picture of Bayer AG logo

BAYN Bayer AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareAdventurousLarge CapMomentum Trap

Brief: Bayer - Askbio Announces Completion Of Enrollment In Phase 2 Clinical Trial Of AB-1002

April 1 (Reuters) - BAYER AG BAYGn.DE:

ASKBIO ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE 2 CLINICAL TRIAL OF AB-1002 INVESTIGATIONAL GENE THERAPY FOR HEART FAILURE

Further company coverage: [BAYGn.DE]

 (Gdansk Newsroom)

 ((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));;))

Recent news on Bayer AG

See all news